N

NovaBay Pharmaceuticals Inc
AMEX:NBY

Watchlist Manager
NovaBay Pharmaceuticals Inc
AMEX:NBY
Watchlist
Price: 12.73 USD -2.38% Market Closed
Market Cap: 1.6B USD

Wall Street
Price Targets

NBY Price Targets Summary
NovaBay Pharmaceuticals Inc

There are no price targets for NBY.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
NovaBay Pharmaceuticals Inc Competitors:
Price Targets
HROW
Harrow Health Inc
50% Upside
4015
Jamjoom Pharmaceuticals Factory Company SJSC
12% Upside
DRREDDY
Dr Reddy's Laboratories Ltd
13% Upside
PPLPHARMA
Piramal Pharma Ltd
47% Upside
300452
Anhui Sunhere Pharmaceutical Excipients Co Ltd
13% Upside
IOLCP
IOL Chemicals and Pharmaceuticals Ltd
49% Upside
600557
Jiangsu Kanion Pharmaceutical Co Ltd
45% Upside
ORCHPHARMA
Orchid Pharma Ltd
32% Upside

Revenue
Forecast

Revenue Estimate
NovaBay Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for NovaBay Pharmaceuticals Inc's revenue is 16%. The projected CAGR for the next 2 years is 13%.

16%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
NovaBay Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
NovaBay Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-84%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NBY's stock price target?
Not Available

NBY doesn't have any price targets made by Wall Street professionals.

What is NovaBay Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for NovaBay Pharmaceuticals Inc's revenue is 16%. The projected CAGR for the next 2 years is 13%.

Back to Top